Table: begin end state 1 17 cytoplasmic 18 40 transmembrane 41 45 non-cytoplasmic 46 66 transmembrane 67 93 cytoplasmic 94 118 transmembrane 119 124 non-cytoplasmic 125 147 transmembrane 148 155 cytoplasmic 156 175 transmembrane 176 202 non-cytoplasmic 203 226 transmembrane 227 246 cytoplasmic 247 265 transmembrane 266 283 non-cytoplasmic 284 305 transmembrane 306 334 cytoplasmic 335 356 transmembrane 357 361 non-cytoplasmic 362 384 transmembrane 385 404 cytoplasmic 405 425 transmembrane 426 430 non-cytoplasmic 431 449 transmembrane 450 466 cytoplasmic
Input: >RR42_RS05070 MVQREQGLHRSLKPAQLAMIAIGGAIGTGLFMGSGFAIGFAGPGVLLSYAIGALVTLLLM GCLAEMTVAHPTSGSFGAYAEHYVSPLAGFLVRYAYWASIVLAVGTEVTAVALYMGYWFP QVPAWFWIVSFSAALILINLVGVGIFGAVEYLFSMVKIVAIVAFILVAAYIVFGAPGSTG SGAAGAGFHHYTAHGGFLPNGLWGMWVAVIVSIFSYLSIEMIAVAAGEAQDPERAVLQAF RSTMIRLGLFYLLTLALMLAIVPWNQAGAQKSPFVQVMEAIHVPGAAAIINFVVLIAALS AMNSQLYITTRTMFSLARAGQAPRSFGEVSKRGIPVRALLLSSIGIALATGLNVFYPGNA FLLMMAISMFGALFTWFMIFVTHYRFRRQWAAAGNRPLAFRMRGFPLLTLLGAGMMLAIM LTTLLTDAFRMTLITGIPFLAALSVAYLLRFRHRAAPAPLPANDAA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server